CRBP (STOCKS)
Corbus Pharmaceuticals Holdings, Inc.
$8.320000
+0.130000 (+1.59%)
Prev close: $8.190000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Yuval Cohen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $154.43M
- Employees
- 28
- P/E (TTM)
- -1.43
- P/B (TTM)
- 1.15
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.23 | $-1.24 | +0.0144 | +1.16% |
|
Dec 2025 (Q4)
|
$-1.25 | $-1.61 | +0.3575 | +22.24% |
|
Sep 2025 (Q3)
|
$-1.90 | $-1.74 | -0.1586 | -9.11% |
|
Jun 2025 (Q2)
|
$-1.44 | $-1.54 | +0.1022 | +6.63% |
Financial Statements
| Revenues | $5.25M |
| Benefits Costs and Expenses | $89.78M |
| Costs And Expenses | $89.78M |
| Nonoperating Income/Loss | $5.31M |
| Operating Expenses | $89.84M |
| Depreciation and Amortization | $201.00K |
| Research and Development | $74.27M |
| Other Operating Expenses | $15.47M |
| Operating Income/Loss | -$89.84M |
| Income/Loss From Continuing Operations After Tax | -$84.53M |
| Income/Loss From Continuing Operations Before Tax | -$84.53M |
| Net Income/Loss | -$84.53M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$78.54M |
| Net Income/Loss Attributable To Parent | -$84.53M |
| Net Income/Loss Available To Common Stockholders, Basic | -$84.53M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.74 |
| Diluted Earnings Per Share | -$5.74 |
| Basic Average Shares | 44,321,164 |
| Diluted Average Shares | 44,321,164 |
| Assets | $144.48M |
| Current Assets | $143.57M |
| Noncurrent Assets | $914.00K |
| Fixed Assets | $116.00K |
| Other Non-current Assets | $798.00K |
| Liabilities | $18.14M |
| Current Liabilities | $18.14M |
| Accounts Payable | $435.00K |
| Wages | $1.23M |
| Other Current Liabilities | $16.47M |
| Noncurrent Liabilities | $0.00 |
| Equity | $126.34M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $126.34M |
| Liabilities And Equity | $144.48M |
| Net Cash Flow From Operating Activities | -$73.64M |
| Net Cash Flow From Operating Activities, Continuing | -$73.64M |
| Net Cash Flow From Investing Activities | $2.69M |
| Net Cash Flow From Investing Activities, Continuing | $2.69M |
| Net Cash Flow From Financing Activities | $82.24M |
| Net Cash Flow From Financing Activities, Continuing | $82.24M |
| Net Cash Flow | $11.29M |
| Net Cash Flow, Continuing | $11.29M |
| Comprehensive Income/Loss | -$84.67M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$84.67M |
| Other Comprehensive Income/Loss | -$138.00K |